This Medicine requires a physician's prescription.

Generic Name: Amlodipine Besilate Atorvastatin Calcium

Brand Name: Norvasc® Protect

Strength: 5mg / 20mg

Form: Tablet

Manufacturer: Pfizer Manufacturing

Marketing Authorized Holder: Pf Ofg Philippines, Inc.

Classification: Calcium Antagonists / Dyslipidaemic Agents

Indication/Uses: Patients at increased CV risk due to the presence of HTN & dyslipidemia &/or symptomatic CHD expressed as angina w/ dyslipidemia &/or prevention of CV complications in hypertensive patients. Amlodipine besilate: 1st-line treatment of HTN & myocardial ischemia whether due to fixed obstruction (stable angina) &/or vasospasm/vasoconstriction (Prinzmetal's or variant angina) of coronary vasculature. Reduce the risk of fatal CHD, non-fatal MI & stroke; coronary revascularization procedures & the need for hospitalization due to angina in patients w/ CAD. Atorvastatin Ca: Adjunct to diet for the treatment of patients w/ elevated total cholesterol (total-C), LDL cholesterol (LDL-C), apolipoprotein B (apo B) & triglycerides (TG). Increase HDL cholesterol (HDL-C) in patients w/ primary hypercholesterolemia (heterozygous familial & nonfamilial hypercholesterolemia), combined (mixed) hyperlipidemia (Fredrickson types IIa & IIb), elevated serum TG levels (Fredrickson type IV), & in patients w/ dysbetalipoproteinemia (Fredrickson type III) who do not respond adequately to diet. Reduction of total-C & LDL-C in patients w/ homozygous familial hypercholesterolemia. Reduce the risk of fatal CHD & non-fatal MI, stroke, & revascularization procedures & angina pectoris in patients w/o clinically evident CV disease, & w/ or w/o dyslipidemia but w/ multiple risk factors for CHD (eg, smoking, HTN, diabetes, low HDL-C or family history of early CHD). Reduce the risk of non-fatal MI, fatal & non-fatal stroke, revascularization procedures, hospitalization for CHF & angina in patients w/ clinically evident CHD. Adjunct to diet to reduce total-C, LDL-C & apo B levels in boys & postmenarchal girls 10-17 yr w/ heterozygous familial hypercholesterolemia.